Study of a diabetes drug for recovery after bleeding stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a medicine called a GLP-1 receptor agonist (similar to diabetes drugs) can improve recovery after a specific type of bleeding stroke. The study aims to see if this drug can reduce brain swelling and help patients regain function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a bleeding stroke in a specific area of the brain (the putamen or thalamus) with a certain amount of bleeding seen on a CT scan.
- Your stroke symptoms must be moderate to severe, but you must still be somewhat responsive (NIHSS score between 6 and 25, GCS score at least 10).
- You must start the trial within 24 hours of your stroke symptoms beginning.
- Before this stroke, you should have been able to live independently (mRS score of 2 or less).
- You must not have had surgery planned for the bleeding, and you must not be taking blood thinners or have a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial checks if adding an interleukin-6 receptor inhibitor (a drug that reduces inflammation) to standard emergency clot removal can improve recovery for people with a severe stroke affecting the back part of the brain (posterior circulation). It is for patients who need urgent treatment within 24 hours of symptom onset.
This trial tests a clot-busting drug called tenecteplase given directly into the brain bleed through a thin tube. It may help reduce damage and improve recovery for people with a certain type of brain hemorrhage.
This trial tests whether a medication commonly used for diabetes can help patients who had a stroke due to a blocked large artery in the brain. The drug is given as an injection after the standard procedure to remove the blood clot, and researchers will see if it leads to better recovery.
This trial tests whether a drug called semaglutide (usually used for diabetes) can improve brain recovery when given after a stroke clot removal procedure. You may receive the drug or a placebo, and researchers will check your neurological outcomes.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.